Clinical Trial Finder

Filters

Zip code

Distance radius

Age

Gender

Male

Female

Patient status?

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

I have a brain tumor

I am a healthy volunteer

Type of trial?

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.

Searching Both is inclusive of interventional and observational studies.

Both

Observational

Interventional

Phase?

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Keyword

You can narrow your results further by searching each trial’s description for a specific word. Keep in mind that this will search the full description. We recommend carefully reviewing each trial information to ensure that it is an appropriate fit for you.

Astrocytoma

Diffuse Intrinsic Pontine Glioma/DIPG

Ependymoma

Glioblastoma/GBM

Meningioma

Oligodendroglioma

Newly Diagnosed/First Occurence

Recurrent

Metastatic

2101 - 2101 of 2101 Trials

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

This is an intermediate-size expanded access protocol to provide ONC201 to patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 through clinical trials.

2 Years and Over
Available

Learn More

← Previous 1 … 205 206 207 208 209 210 211 Next →

Powered By

The content provided by NBTS on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. For a full description of terms please refer to: Terms, Conditions & Privacy

Search By Connection:

Patients & Families Advocates Supporters Researchers Industry Media

Brain Tumor Info
About us
Advance research
Advocate for Issues
Join the Fight

Donate

Terms Privacy Copyright

Facebook Twitter YouTube Flickr

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas